ClinConnect ClinConnect Logo
Search / Trial NCT02921412

Performance of Fanfilcon A Toric Lenses After at Least One Month Wearing Enfilcon A Toric Lenses

Launched by COOPERVISION, INC. · Sep 29, 2016

Trial Information

Current as of April 26, 2025

Completed

Keywords

ClinConnect Summary

The aim of this study is to determine if adapted contact lens wearers enfilcon A toric lenses can be confidently refit into fanfilcon A toric lenses and can be successful after one month of daily wear.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • A person is eligible for inclusion in the study if he/she:
  • Is between 18 and 40 years of age (inclusive)
  • Has had a self-reported eye exam in the last two years
  • Is a habitual soft toric lens wearer
  • Can be successfully fit with study lenses (≥ grade 2 fit acceptance)
  • Has a contact lens spherical prescription between -1.00 to -6.00D with a cylinder between -0.75 and -1.75D (Diopters) (inclusive)
  • Has a spectacle cylinder of at least 0.75D in each eye.
  • Can achieve best corrected spectacle refraction distance visual acuity of 20/25 (0.10 logMAR) or better in each eye.
  • Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses.
  • Has clear corneas and no active ocular disease
  • Has read, understood and signed the information consent letter
  • Has a contact lens refraction that fits within the available parameters of the study lenses
  • Is willing to comply with the wear schedule (at least 5 days per week, \> 8 hours/day assuming there are no contraindications for doing so)
  • Is willing to comply with the visit schedule.
  • Exclusion Criteria:
  • A person will be excluded from the study if he/she:
  • Has a history of not achieving comfortable CL (Contact Lens) wear (5 days per week; \> 8 hours/day)
  • Presents with clinically significant anterior segment abnormalities
  • Presents with ocular or systemic disease or need of medications which might interfere with contact lens wear
  • * Presents with slit lamp findings that would contraindicate contact lens wear such as:
  • Pathological dry eye or associated findings
  • Significant pterygium, pinguecula, or corneal scars within the visual axis
  • Neovascularization \> 0.75 mm in from of the limbus
  • Anterior uveitis or iritis (or history in past year)
  • Seborrheic eczema of eyelid region, Seborrheic conjunctivitis
  • History of corneal ulcers or fungal infections
  • Poor personal hygiene
  • Has a known history of corneal hypoesthesia (reduced corneal sensitivity)
  • Has aphakia, keratoconus or a highly irregular cornea.
  • Has presbyopia or has dependence on spectacles for near work over the contact lenses.
  • Has undergone corneal refractive surgery.
  • Is participating in any other type of eye related clinical or research study.
  • Is frequently using rewetting/ lubricating eye drops (more than once per day)

About Coopervision, Inc.

CooperVision, Inc. is a global leader in the contact lens industry, dedicated to advancing the science of vision care through innovative products and clinical research. With a commitment to enhancing the quality of life for millions of wearers worldwide, the company specializes in developing a diverse range of contact lenses, including those for myopia control, astigmatism, and presbyopia. CooperVision actively engages in clinical trials to ensure the safety, efficacy, and comfort of its products, while also contributing to the broader understanding of eye health and vision correction. By fostering partnerships with healthcare professionals and researchers, CooperVision aims to drive advancements in vision care and provide exceptional solutions that meet the evolving needs of eye care practitioners and their patients.

Locations

Spokane, Washington, United States

Miami, Florida, United States

Closter, New Jersey, United States

New York, New York, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials